Lineage Cell Therapeutics Inc (LCTX) Stock Price, Quote & News

Company Profile

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the tre...

Industry: Biotechnology

Sector: Healthcare

Phone: 442 287 8990

Website: www.lineagecell.com

Address:

2173 Salk Avenue, Suite 200, Carlsbad, United States

Invest2live Jan. 14 at 4:32 AM

$LCTX $SKYT $XERS $SKYT 155% already; congrats 🎈 🎉🎊 Check out $PHR and $AKBA with similar potential

0 · Reply

qwertylicious2003 Jan. 13 at 10:51 PM

$LCTX don’t remember seeing this posted, but here’s a phase 2b update from Regenerative Patch Technologies https://www.retinalphysician.com/news/2025/first-patients-treated-in-patch-amd-study/

1 · Reply

DiligentInvesting Jan. 13 at 10:47 PM

$AVXL A break of $5 could be interesting. Also check $SLS and $LCTX for derisked future blockbuster drug companies on the verge of a steep rerate upward.

0 · Reply

JohnPDaly Jan. 13 at 9:40 PM

$LCTX

1 · Reply

SPS614 Jan. 13 at 9:13 PM

$LCTX I feel like @MR_PINKS should have an expression for days when this stock shows just how bipolar it is. Something like, “Don’t do it!! Don’t go there!!”

1 · Reply

qwertylicious2003 Jan. 13 at 7:34 PM

$LCTX Anyone invest with JPM that can get in to Culley's presentation tomorrow?

2 · Reply

Ablidy Jan. 13 at 7:27 PM

$LCTX is presenting at the JP Morgan Health Conference 2026 at Wednesday 9:00 am PST there is link to the meeting for live telecast http://Jpmorgan.metameeting.net Need to register with corporate email or invitation from JP Morgan rep.

2 · Reply

Logic102 Jan. 13 at 7:18 PM

$LCTX Any thoughts from the peanut gallery on what news will be the next thing to move the share price one direction or the other?

1 · Reply

Evilmarine Jan. 13 at 5:53 PM

$LCTX ZZZ 😴

0 · Reply

Gromit00 Jan. 13 at 5:45 PM

$LCTX someone should check the patents to see if there are any TD1 developments. 😉

1 · Reply

Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

Jan 5, 2026, 8:00 AM EST - 9 days ago

Lineage Cell Therapeutics Issues Letter to Stockholders

Nov 13, 2025, 4:10 AM EST - 2 months ago

Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy

Nov 6, 2025, 10:06 PM EST - 2 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:01 PM EST - 2 months ago

Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Oct 30, 2025, 8:00 AM EDT - 2 months ago

Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025

Sep 13, 2025, 1:44 AM EDT - 4 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Prepared Remarks Transcript

Sep 8, 2025, 8:00 AM EDT - 4 months ago

Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes

Sep 2, 2025, 8:00 AM EDT - 4 months ago

Lineage Cell Therapeutics to Present at September 2025 Investor Conferences

Aug 26, 2025, 8:00 AM EDT - 5 months ago

Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss

Aug 12, 2025, 9:16 PM EDT - 5 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:01 PM EDT - 5 months ago

Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 5, 2025, 8:00 AM EDT - 5 months ago

Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025

Aug 4, 2025, 8:00 AM EDT - 5 months ago

Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury

Jun 23, 2025, 7:39 AM EDT - 7 months ago

Two Biotech Stocks Poised For Big Moves On Monday

SANA

Jun 23, 2025, 7:00 AM EDT - 7 months ago

OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025

Jun 5, 2025, 8:00 AM EDT - 7 months ago

Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium

May 14, 2025, 8:00 AM EDT - 8 months ago

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

May 13, 2025, 5:53 PM EDT - 8 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 8 months ago

Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 8:00 AM EDT - 8 months ago

RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025

May 1, 2025, 8:00 AM EDT - 9 months ago

Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025

Apr 22, 2025, 8:00 AM EDT - 9 months ago

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium

Apr 21, 2025, 8:00 AM EDT - 9 months ago

Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)

Mar 10, 2025, 8:16 PM EDT - 11 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Q4 2024 Earnings Call Transcript

Mar 10, 2025, 4:05 PM EDT - 11 months ago

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 5, 2025, 8:00 AM EST - 11 months ago

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025

Feb 11, 2025, 8:00 AM EST - 1 year ago

Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury

Feb 4, 2025, 8:00 AM EST - 1 year ago

Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference

Jan 27, 2025, 4:05 PM EST - 1 year ago

Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering

Nov 21, 2024, 5:00 PM EST - 1 year ago

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering

Nov 20, 2024, 8:00 AM EST - 1 year ago

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

Nov 14, 2024, 9:39 PM EST - 1 year ago

Lineage Cell Therapeutics, Inc. (LCTX) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:01 PM EST - 1 year ago

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024

Oct 14, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit

Sep 25, 2024, 8:00 AM EDT - 1 year ago

OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Aug 10, 2024, 12:03 AM EDT - 1 year ago

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 1, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index

May 30, 2024, 8:00 AM EDT - 1 year ago

Lineage to Present at 2024 BIO International Convention

May 21, 2024, 8:00 AM EDT - 1 year ago

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

May 10, 2024, 12:33 AM EDT - 1 year ago

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:01 PM EDT - 1 year ago

Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 6, 2024, 8:00 AM EDT - 1 year ago

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

May 2, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Invest2live Jan. 14 at 4:32 AM

$LCTX $SKYT $XERS $SKYT 155% already; congrats 🎈 🎉🎊 Check out $PHR and $AKBA with similar potential

0 · Reply

qwertylicious2003 Jan. 13 at 10:51 PM

$LCTX don’t remember seeing this posted, but here’s a phase 2b update from Regenerative Patch Technologies https://www.retinalphysician.com/news/2025/first-patients-treated-in-patch-amd-study/

1 · Reply

DiligentInvesting Jan. 13 at 10:47 PM

$AVXL A break of $5 could be interesting. Also check $SLS and $LCTX for derisked future blockbuster drug companies on the verge of a steep rerate upward.

0 · Reply

JohnPDaly Jan. 13 at 9:40 PM

$LCTX

1 · Reply

SPS614 Jan. 13 at 9:13 PM

$LCTX I feel like @MR_PINKS should have an expression for days when this stock shows just how bipolar it is. Something like, “Don’t do it!! Don’t go there!!”

1 · Reply

qwertylicious2003 Jan. 13 at 7:34 PM

$LCTX Anyone invest with JPM that can get in to Culley's presentation tomorrow?

2 · Reply

Ablidy Jan. 13 at 7:27 PM

2 · Reply

Logic102 Jan. 13 at 7:18 PM

$LCTX Any thoughts from the peanut gallery on what news will be the next thing to move the share price one direction or the other?

1 · Reply

Evilmarine Jan. 13 at 5:53 PM

$LCTX ZZZ 😴

0 · Reply

Gromit00 Jan. 13 at 5:45 PM

$LCTX someone should check the patents to see if there are any TD1 developments. 😉

1 · Reply

JP73 Jan. 13 at 4:29 PM

$LCTX Where o where is that buyer to be found? He's out there , but hiding this AM.

0 · Reply

qwertylicious2003 Jan. 13 at 3:08 PM

$LCTX

1 · Reply

JohnPDaly Jan. 13 at 2:59 PM

$LCTX https://x.com/lineagecell/status/2011088190157853085?s=12

0 · Reply

CMAC1211 Jan. 13 at 2:42 PM

$LCTX - Just a reminder that this Friday (Jan 16) is a derivative decision day for the stock. Expect some price fluctuation...

1 · Reply

MR_PINKS Jan. 13 at 1:28 PM

$LCTX The complement inhibitor sham is behind us....Let's Go C-MAN!

0 · Reply

MR_PINKS Jan. 13 at 12:55 PM

$LCTX I would think the abstract submissions for ARVO 2026 acceptance/Denial letters will be coming out soon! We have two MAJOR CONFERENCES in 1st Half 2026! LET'S GET IT ON FOLKS! IT'S TIME..........to unveil OpRegen to the world!

0 · Reply

requiem13 Jan. 13 at 6:18 AM

$LCTX

0 · Reply

primordialATOM Jan. 12 at 10:28 PM

$LCTX ROCHE could boast about their 9 now 10 successful ophthalmology treatments ? OR ??? Release something nice about LCTX's future progress ??? One can always hope .....MAYBE something even more dynamic for the share price ???

2 · Reply

qwertylicious2003 Jan. 12 at 10:27 PM

$LCTX Nanoscope patent https://www.ophthalmologytimes.com/view/nanoscope-secures-new-us-patent-for-multi-characteristic-opsin-mco-technology-platform?utm_content=365196035&utm_medium=social&utm_source=linkedin&hss_channel=lcp-18249135

2 · Reply

MR_PINKS Jan. 12 at 9:19 PM

$LCTX This has been a nice strong consolidation level here peeps.....we're close! The music is just starting!

0 · Reply

z06forum Jan. 12 at 7:18 PM

$LCTX @requiem13 You said it perfectly.... Lineage is creating a place where everyone wins - Patients , Shareholders, partners, Dr's

0 · Reply

MR_PINKS Jan. 12 at 6:49 PM

$LCTX You nibbling Jorey?

2 · Reply

Market Cap	405.38M
Revenue (ttm)	9.50M
Net Income (ttm)	-18.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-195.89%
Debt to Equity Ratio	0.00

Volume	829,600
Avg Vol	1,723,892
Day's Range	N/A - N/A
Shares Out	230.33M
Stochastic %K	35%
Beta	1.74
Analysts	Strong Sell
Price Target	$4.17